Antibiotic Therapy in Preterm Premature Rupture of the Membranes

Journal of Obstetrics and Gynaecology Canada

Volumn 31, Issue 9, 2009, Pages 863-867

  Yudin, Mark H ^a   van Schalkwyk, Julie ^a   Eyk, Nancy Van ^a   Boucher, Marc ^a   Castillo, Eliana ^a   Cormier, Beatrice ^a   Gruslin, Andrée ^a   Money, Deborah M ^a   Murphy, Kellie ^a   Ogilvie, Gina ^a   Paquet, Caroline ^a   Steenbeek, Audrey ^a   Wong, Thomas ^a   Gagnon, Robert ^a   Hudon, Lynda ^a   Basso, Melanie ^a   Bos, Hayley ^a   Delisle, Marie France ^a   Farine, Dan ^a   Grabowska, Kirsten ^a   Menticoglou, Savas ^a   Mundle, William Robert ^a   Murphy Kaulbeck, Lynn Carole ^b   Ouellet, Annie ^a   Pressey, Tracy ^a   Roggensack, Anne ^a   more..

^a Vancouver ^*  (Canada)

^b NONE   (Canada)

Author keywords

Antibiotic therapy; Maternal morbidity; Neonatal morbidity; Preterm premature rupture of the membranes

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ANTIBIOTIC THERAPY; ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; CANADA; HUMAN; INFECTION; MATERNAL INFECTION; MEDICAL DECISION MAKING; MEDICAL SOCIETY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PREGNANCY COMPLICATION; PREMATURE FETUS MEMBRANE RUPTURE; PREVENTIVE MEDICINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGISTER; SYSTEMATIC REVIEW; SYSTEMATIC REVIEW (TOPIC); FEMALE; GESTATIONAL AGE; MICROBIOLOGY; PREGNANCY; REVIEW;

ANTI-BACTERIAL AGENTS; CANADA; FEMALE; FETAL MEMBRANES, PREMATURE RUPTURE; GESTATIONAL AGE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 75349106088     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)34305-5     Document Type: Article

References (20)

1. Klein L.L., Gibbs R.S. Use of microbial cultures and antibiotics in the prevention of infection-associated preterm birth. Am J Obstet Gynecol 2004, 190:1493-1502.
2. Joseph K.S., Kramer M.S., Marcoux S., Ohlsson A., Wen S.W., Allen A., et al. Determinants of preterm birth rates in Canada from 1981 to 1983 and from 1992 through 1994. N Engl J Med 1998, 339:1434-1439.
3. Goldenberg R.L. The management of preterm labor. Obstet Gynecol 2002, 100:1020-1037.
4. Romero R., Athayde N., Maymon E., Pacora P., Bahado-Singh R. Premature rupture of the membranes. Medicine of the fetus and the mother 1999, 1581-1625. Lippincott-Raven, Philadelphia. A. Reece, J. Hobbins (Eds.).
5. Romero R., Espinoza J., Chaiworapongsa T., Kalache K. Infection and prematurity and the role of preventive strategies. Semin Neonatol 2002, 7:259-274.
6. Goncalves L.F., Chaiworapongsa T., Romero R. Intrauterine infection and prematurity. Ment Retard Dev Disabil Res Rev 2002, 8:3-13.
7. Mercer B.M. Preterm premature rupture of the membranes. Obstet Gynecol 2003, 101:178-193.
8. Goldenberg R.L., Hauth J.C., Andrews W.W. Intrauterine infection and preterm delivery. N Engl J Med 2000, 342:1500-1507.
9. Kenyon S., Boulvain M., Neilson J. Antibiotics for preterm rupture of the membranes: a systematic review. Obstet Gynecol 2004, 104:1051-1057.
10. Mercer B.M., Miodovnik M., Thurnau G.R., Goldenberg R.L., Ramsey R.D., Rabello Y.A., et al. Antibiotic therapy for reduction of infant morbidity after preterm premature rupture of the membranes; a randomized controlled trial. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. JAMA 1997, 278:989-995.
11. Kenyon S.L., Taylor D.J., Tarnow-Mordi W., ORACLE Collaborative Group Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial. Lancet 2001, 357:979-988.
12. Hannah M. Antibiotics for preterm prelabour rupture of membranes and preterm labour. Lancet 2001, 357:973-974.
13. Kenyon S., Pike K., Jones D.R., Brocklehurst P., Marlow N., Salt A., Taylor D.J. Childhood outcomes after prescription of antibiotics to pregnant women with preterm rupture of the membranes: 7-year follow-up of the ORACLE I trial. Lancet 2008, 372:1310-1318.
14. Ryo E., Ikeya M., Sugimoto M. Clinical study of the effectiveness of imipenem/cilastatin sodium as the antibiotics of first choice in the expectant management of patients with preterm premature rupture of membranes. J Infect Chemother 2005, 11(1):32-36.
15. August F.N., Becker C., van B.A., Bauer K., Hopp H. Antibiotic therapy for preterm premature rupture of membranes- results of a multicenter study. J Perinat Med 2006, 34(3):203-206.
16. Segel S.Y., Miles A.M., Clothier B., Parry S., Macones G.A. Duration of antibiotic therapy after preterm premature rupture of fetal membranes. Am J Obstet Gynecol 2003, 189:799-802.
17. Kenyon S., Boulvain M., Neilson J. Antibiotics for preterm rupture of membranes. Cochrane Database Syst Rev 2003, (2):CD001058. Art. No.:CD001058. 10.1002/14651858.
18. Naef R.W., Allbert J.R., Ross E.L., Weber B.M., Martin R.W., Morrison J.C. Premature rupture of membranes at 34 to 37 weeks' gestation: aggressive versus conservative management. Am J Obstet Gynecol 1998, 178:126-130.
19. Mercer B.M., Crocker L., Boe N., Sibai B. Induction versus expectant management in PROM with mature amniotic fluid at 32-36 weeks: a randomized trial. Am J Obstet Gynecol 1993, 82:775-782.
20. Woolf S.H., Battista R.N., Angerson G.M., Logan A.G., Eel W. Canadian Task Force on Preventive Health Care. New grades for recommendations from the Canadian Task Force on Preventive Health Care. CMAJ 2003, 169(3):207-208.